UCP1 and lung cancer: PPARγ can activate AMPK in adipose tissue (96).AMPK enhances PPARγ deacetylation, thermogenic proteins (UCP-1) (98).Rosiglitazone increases AMPK and AKT in lung cancer models (Muscle Preservation) (13).